Trial Profile
Effects of immunomodulatory therapy on gonadal function in women with autoimmune premature ovarian insufficiency
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2022
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions
- 29 May 2018 New trial record